Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1997 1
2001 1
2002 1
2003 2
2004 1
2007 2
2008 1
2009 1
2011 4
2012 1
2013 1
2014 5
2015 7
2016 10
2017 17
2018 18
2019 16
2020 14
2021 9
2022 12
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 31395785

111 results

Results by year

Filters applied: . Clear all
Page 1
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies.
Boettcher S, Miller PG, Sharma R, McConkey M, Leventhal M, Krivtsov AV, Giacomelli AO, Wong W, Kim J, Chao S, Kurppa KJ, Yang X, Milenkowic K, Piccioni F, Root DE, Rücker FG, Flamand Y, Neuberg D, Lindsley RC, Jänne PA, Hahn WC, Jacks T, Döhner H, Armstrong SA, Ebert BL. Boettcher S, et al. Science. 2019 Aug 9;365(6453):599-604. doi: 10.1126/science.aax3649. Science. 2019. PMID: 31395785 Free PMC article.
Limited importance of the dominant-negative effect of TP53 missense mutations.
Stoczynska-Fidelus E, Szybka M, Piaskowski S, Bienkowski M, Hulas-Bigoszewska K, Banaszczyk M, Zawlik I, Jesionek-Kupnicka D, Kordek R, Liberski PP, Rieske P. Stoczynska-Fidelus E, et al. BMC Cancer. 2011 Jun 13;11:243. doi: 10.1186/1471-2407-11-243. BMC Cancer. 2011. PMID: 21668955 Free PMC article.
Mutational processes shape the landscape of TP53 mutations in human cancer.
Giacomelli AO, Yang X, Lintner RE, McFarland JM, Duby M, Kim J, Howard TP, Takeda DY, Ly SH, Kim E, Gannon HS, Hurhula B, Sharpe T, Goodale A, Fritchman B, Steelman S, Vazquez F, Tsherniak A, Aguirre AJ, Doench JG, Piccioni F, Roberts CWM, Meyerson M, Getz G, Johannessen CM, Root DE, Hahn WC. Giacomelli AO, et al. Nat Genet. 2018 Oct;50(10):1381-1387. doi: 10.1038/s41588-018-0204-y. Epub 2018 Sep 17. Nat Genet. 2018. PMID: 30224644 Free PMC article.
Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations.
Merkle FT, Ghosh S, Kamitaki N, Mitchell J, Avior Y, Mello C, Kashin S, Mekhoubad S, Ilic D, Charlton M, Saphier G, Handsaker RE, Genovese G, Bar S, Benvenisty N, McCarroll SA, Eggan K. Merkle FT, et al. Nature. 2017 May 11;545(7653):229-233. doi: 10.1038/nature22312. Epub 2017 Apr 26. Nature. 2017. PMID: 28445466 Free PMC article.
Differences in somatic TP53 mutation type in breast tumors by race and receptor status.
Pollock NC, Ramroop JR, Hampel H, Troester MA, Conway K, Hu JJ, Freudenheim JL, Olopade OI, Huo D, Ziv E, Neuhausen SL, Stevens P, McElroy JP, Toland AE. Pollock NC, et al. Breast Cancer Res Treat. 2022 Apr;192(3):639-648. doi: 10.1007/s10549-022-06509-3. Epub 2022 Mar 14. Breast Cancer Res Treat. 2022. PMID: 35286522 Free PMC article.
111 results